Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Multicentre Open-label Study to Investigate the Non-inferiority of Itopride Hydrochloride 150mg Once Daily Versus Itopride Hydrochloride 50 mg Thrice Daily in Subjects With Functional (Non-ulcer) Dyspepsia or Chronic Gastritis

NCT06217393 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT06217393
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06217393 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Multicentre Open-label Study to Investigate the Non-inferiority of Itopride Hydrochloride 150mg Once Daily Versus Itopride Hydrochloride 50 mg Thrice Daily in Subjects With Functional (Non-ulcer) Dyspepsia or Chronic Gastritis
Lead sponsor
Abbott
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2024
Completion date
February 28, 2025
Enrollment
564 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

functional dyspepsia